• Vascular Annual Meeting^®
• Registration
• Hotel Reservations
• Schedule-at-a-Glance
• Program-in-Detail
• Wednesday, June 9 - Postgraduate Courses Day
• Thursday, June 10
• Friday, June 11
• Saturday, June 12
• Sunday, June 13
• International Attendee Information
• General Information
• New in 2010
• Call for Abstracts
• Speaker Information
• Exhibitor Information
• Alumni Association Information
• Future Meeting Dates
• 2009 Meeting Information
• Contact Us

Home > Vascular Annual Meeting^® > SS11. Aggressive Lipid-Lowering Is More Effective...

SS11. Aggressive Lipid-Lowering Is More Effective than Moderate Lipid-Lowering Treatment in Carotid Plaque Stabilization

Nikolaos P.E. Kadoglou1, Nikolaos Sailer1, Anestis Moumtzouoglou1, Alkistis Kapelouzou2, Grigorios Fotiadis1, Ioulia Vitta1, Ioannis Kakisis3, Efthimios Avgerinos3, Thomas Gerasimidis1, Panayotis Karayannacos2, Christos D. Liapis1
1Aristotle's University of Thessaloniki, Thessaloniki, Greece2Foundation of Biomedical Research,Academy of Athens, Athens, Greece3University of Athens, Athens, Greece

OBJECTIVES: Atherosclerotic plaque stabilization is a promising strategy to prevent cerebrovascular events in patients with moderate carotid stenosis. This prospective study examined whether intensive lipid-lowering therapy is more effective in increasing carotid plaque echogenicity, assessed by Gray-Scale Median (GSM) score, and suppressing serum levels of osteopontin (OPN) and osteoprotegerin (OPG) in patients with carotid stenosis.

METHODS: 120 patients (51M/69F), aged 55-75, with carotid stenosis (NASCET: 40-60% for symptomatic and 40-70% for asymptomatic patients), thus without indications for surgical intervention, were included. Patients with previous use of statins were excluded. Patients were randomized to either intensive lipid-lowering therapy (Group A; n=60: target LDL-C<70mg/dl) or moderate lipid-lowering therapy (Group B; n=60: target LDL-C<100mg/dl). The ratio symptomatic/asymptomatic patients was equivalent in groups. All patients were treated with atorvastatin (10-80mg gradual titration) to reach the target. Biochemical parameters and GSM score were assessed at baseline and after 12 months. Independent samples t-test and Pearson correlation were used for statistical analysis (p<0.05).

RESULTS: There were no significant differences between groups at baseline. Group A showed a more pronounced improvement in lipid profile compared with group B (p<0.05). Moreover atorvastatin treatment significantly suppressed of hsCRP, OPN and OPG serum levels across LDL levels downregulation (p<0.05). ). Remarkable increment of carotid plaque echogenicity was noted in both groups, but that was considerably higher in group A than group B (Table 1).Notably GSM score augmentation was inversely associated with OPN (p=0.031) and OPG (p=0.002) changes in the whole study group.

CONCLUSIONS: Intensive lipid-lowering therapy rather than moderate lipid-lowering therapy is more effective in increasing echogenicity of carotid plaques. This effect seems to be mediated by OPN and OPG suppression.

AUTHOR DISCLOSURES: N.P.E. Kadoglou, Project "Pythagoras II"; Common Research Project “Hellas-Slovenia”; Grant by the Onassis Public Benefit Foundation; N. Sailer, None; A. Moumtzouoglou, None; A. Kapelouzou, None; G. Fotiadis, None; I. Vitta, None; I. Kakisis, None; E. Avgerinos, None; T. Gerasimidis, None; P. Karayannacos, None; C.D. Liapis, None.

Table 1.